Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction
NCT00627744
Angina Pectoris, Angina, Unstable
Stockholm, Sweden
View Trial DetailsNCT Number: NCT01406665
Early detection of (pre)diabetes, including impaired glucose tolerance is currently deficient because the best accepted standard, an oral glucose tolerance test (oGTT), is not feasible in a setting of screening or broad case-finding and other current methods lack in sensitivity. A previously reported study, and analysis of retrospective skin autofluorescence (AF) data, suggests that noninvasive skin AF may offer an alternative for detection of (pre)diabetes. The objective is to test the validity of a decision tree based on skin autofluorescence, and some simple clinical characteristics, as a detection tool for diabetes and impaired glucose tolerance. Sensitivity and specificity, positive and negative predictive value of this skin AF based decision model will be compared to those of fasting plasma glucose (FPG), glycated haemoglobin (HbA1c), and to two short questionnaires (Finnish Findrisk, and Cambridge score).
Study design: Skin AF, HbA1c and an oGTT (including an FPG) will be simultaneously performed in at least 120 persons with the characteristics described in the following paragraph. A Findrisk and Cambridge questionnaire will also be collected.
Looking for future studies?
Notify Me20 year and older
All sexes
Observational
Gelre Ziekenhuis, Apeldoorn, Gelderland, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-age >20 years
Exclusion criteria
-known diabetes mellitus
Time frame: individually immediately following test, for study <26 weeks
numbers of true and false positives and negatives for oGTT (WHO criteria)-defined impaired glucose tolerance or diabetes are scored for Skin autofluorescence (based decision tree), FPG and HbA1c
Time frame: individually immediately after test, for study <26 weeks
Findrisk diabetes questionnaire score is based on anthropometric data and questionnaire.
University Medical Center Groningen
Other
Assessment of Value of Skin Autofluorescence in Detecting Diabetes Mellitus or Impaired Glucose Tolerance. Comparison With Fasting Plasma Glucose and Glycated Hb
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00627744
Angina Pectoris, Angina, Unstable
Stockholm, Sweden
View Trial DetailsNCT00063674
Adherence Interventions, Behavior
Palo Alto, California, United States
View Trial DetailsNCT04909632
Diabetes Mellitus, Endocrine System Diseases
Taichung, Taiwan
View Trial DetailsNCT04881383
Diabetes Mellitus, Endocrine System Diseases
Hong Kong
View Trial Details